Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Roger A. Rajewski"'
Autor:
Anuradha Illendula, Jane Gilmour, Jolanta Grembecka, Venkata Sesha Srimath Tirumala, Adam Boulton, Aravinda Kuntimaddi, Charles Schmidt, Lixin Wang, John A. Pulikkan, Hongliang Zong, Mahmut Parlak, Cem Kuscu, Anna Pickin, Yunpeng Zhou, Yan Gao, Lauren Mishra, Mazhar Adli, Lucio H. Castilla, Roger A. Rajewski, Kevin A. Janes, Monica L. Guzman, Constanze Bonifer, John H. Bushweller
Publikováno v:
EBioMedicine, Vol 8, Iss C, Pp 117-131 (2016)
Transcription factors have traditionally been viewed with skepticism as viable drug targets, but they offer the potential for completely novel mechanisms of action that could more effectively address the stem cell like properties, such as self-renewa
Externí odkaz:
https://doaj.org/article/850cfca578ff44cc88f4d9d260010cb6
Autor:
Anuradha Illendula, Jane Gilmour, Jolanta Grembecka, Venkata Sesha Srimath Tirumala, Adam Boulton, Aravinda Kuntimaddi, Charles Schmidt, Lixin Wang, John A. Pulikkan, Hongliang Zong, Mahmut Parlak, Cem Kuscu, Anna Pickin, Yunpeng Zhou, Yan Gao, Lauren Mishra, Mazhar Adli, Lucio H. Castilla, Roger A. Rajewski, Kevin A. Janes, Monica L. Guzman, Constanze Bonifer, John H. Bushweller
Publikováno v:
EBioMedicine, Vol 25, Iss C, p 188 (2017)
Externí odkaz:
https://doaj.org/article/0b1d01d5ffc84fc19361f34993b36b15
Autor:
Sushanta K. Banerjee, Peter J. Van Veldhuizen, Emma Borrego-Diaz, Douglas Burns, Saheli Jha, Snigdha Banerjee, Amlan Das, Inamul Haque, Mehmet Tanol, Roger A. Rajewski, Suman Kambhampati
PDF file - 59KB, Rat 2-ME2 and 2-ME2-PD1 dosing summary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9216869575e6ea044be71e3700c86ba
https://doi.org/10.1158/1535-7163.22498728
https://doi.org/10.1158/1535-7163.22498728
Autor:
Paul J. Limburg, Matthew M. Ames, Sumithra J. Mandrekar, Brent A. Bauer, Ling Jong, Marjorie Perloff, James Crowell, Eva Szabo, Daniel Boring, Cindy L. Fitting, Roger Warndahl, Roger A. Rajewski, John L. Haslam, Katie L. Allen Ziegler, Rui Qin, Chad A. Walden, Joel M. Reid
Perspectives on This Article from Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4505bbd85b68a4a12f798c795942fdd3
https://doi.org/10.1158/1940-6207.22524753
https://doi.org/10.1158/1940-6207.22524753
Autor:
Sushanta K. Banerjee, Peter J. Van Veldhuizen, Emma Borrego-Diaz, Douglas Burns, Saheli Jha, Snigdha Banerjee, Amlan Das, Inamul Haque, Mehmet Tanol, Roger A. Rajewski, Suman Kambhampati
2-Methoxyestradiol (2-ME2) is an endogenous metabolite of estradiol. In preclinical models, 2-ME2 is effective against different types of tumors. Unfortunately, only low systemic concentrations of 2-ME2 can be achieved following oral administration,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54b59b8ee75a277902dad405b0ca682a
https://doi.org/10.1158/1535-7163.c.6535956
https://doi.org/10.1158/1535-7163.c.6535956
Autor:
John H. Bushweller, Yan Gao, Roger A. Rajewski, Anant Shah, Adam Boulton, Anne L. Carlton, Anuradha Illendula, David Wotton, Danielle C. Llaneza, Charles N. Landen
Publikováno v:
Gynecologic Oncology. 149:350-360
Objective Ovarian cancer survival and treatment have improved minimally in the past 20years. Novel treatment strategies are needed to combat this disease. This study investigates the effects of chemical inhibition of the CBFβ/RUNX protein-protein in
Autor:
Isaura M. Frost, Roger A. Rajewski, John H. Bushweller, Trista E. North, Charles Schmidt, Anuradha Illendula, Zaw Min Oo, Wanda Kwan, Yunpeng Zhou, Jolanta Grembecka, Virginie Esain, Nancy A. Speck
Publikováno v:
Leukemia & Lymphoma. 59:2188-2200
The core binding factor (CBF) gene RUNX1 is a target of chromosomal translocations in leukemia, including t(8;21) in acute myeloid leukemia (AML). Normal CBF function is essential for activity of AML1-ETO, product of the t(8;21), and for survival of
Autor:
Lauren Mishra, Mahmut Parlak, Adam Boulton, Cem Kuscu, Venkata Sesha Srimath Tirumala, Mazhar Adli, Yunpeng Zhou, John H. Bushweller, Anuradha Illendula, Yan Gao, Anna Pickin, Charles Schmidt, Jane Gilmour, Kevin A. Janes, John Anto Pulikkan, Roger A. Rajewski, Aravinda Kuntimaddi, Jolanta Grembecka, Lucio H. Castilla, Hongliang Zong, Constanze Bonifer, Monica L. Guzman, Lixin Wang
Publikováno v:
EBioMedicine, Vol 8, Iss C, Pp 117-131 (2016)
Scipedia Open Access
Scipedia SL
Scipedia Open Access
Scipedia SL
Transcription factors have traditionally been viewed with skepticism as viable drug targets, but they offer the potential for completely novel mechanisms of action that could more effectively address the stem cell like properties, such as self-renewa
Autor:
Roger A. Rajewski, Valentino J. Stella
Publikováno v:
International Journal of Pharmaceutics
Graphical abstract
This review presents the early history, the motivation, the research and some of the backstories behind the discovery and development of sulfobutylether-β-cyclodextrin as a novel parenterally safe solubilizer and stabilizer.
This review presents the early history, the motivation, the research and some of the backstories behind the discovery and development of sulfobutylether-β-cyclodextrin as a novel parenterally safe solubilizer and stabilizer.
Autor:
Roger A. Rajewski, Hongliang Zong, Adam Boulton, Yunpeng Zhou, John Anto Pulikkan, Aravinda Kuntimaddi, Anuradha Illendula, John H. Bushweller, Yan Gao, Liting Xue, Monica L. Guzman, Siddhartha Sen, Jolanta Grembecka, Lucio H. Castilla
Publikováno v:
Science. 347:779-784
Toward drugging the undruggable in cancer Many human cancers are characterized by inappropriate activity of transcription factors. These proteins are attractive drug targets in principle, but normalizing their function requires drugs that modulate sp